A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment
Open Access
- 23 February 2021
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 218 (4)
- https://doi.org/10.1084/jem.20201637
Abstract
Despite the development of effective therapies, a substantial proportion of asthmatics continue to have uncontrolled symptoms, airflow limitation, and exacerbations. Transient receptor potential cation channel member A1 (TRPA1) agonists are elevated in human asthmatic airways, and in rodents, TRPA1 is involved in the induction of airway inflammation and hyperreactivity. Here, the discovery and early clinical development of GDC-0334, a highly potent, selective, and orally bioavailable TRPA1 antagonist, is described. GDC-0334 inhibited TRPA1 function on airway smooth muscle and sensory neurons, decreasing edema, dermal blood flow (DBF), cough, and allergic airway inflammation in several preclinical species. In a healthy volunteer Phase 1 study, treatment with GDC-0334 reduced TRPA1 agonist-induced DBF, pain, and itch, demonstrating GDC-0334 target engagement in humans. These data provide therapeutic rationale for evaluating TRPA1 inhibition as a clinical therapy for asthma.Keywords
Funding Information
- Genentech, Inc.
This publication has 107 references indexed in Scilit:
- Neurogenic inflammation and the peripheral nervous system in host defense and immunopathologyNature Neuroscience, 2012
- IgE and mast cells in allergic diseaseNature Medicine, 2012
- Features and development of CootActa crystallographica. Section D, Structural biology, 2010
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthmaProceedings of the National Academy of Sciences of the United States of America, 2009
- Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gasesThe FASEB Journal, 2008
- Caffeine activates mouse TRPA1 channels but suppresses human TRPA1 channelsProceedings of the National Academy of Sciences of the United States of America, 2008
- Using guinea pigs in studies relevant to asthma and COPDPulmonary Pharmacology & Therapeutics, 2008
- Expression and function of the ion channel TRPA1 in vagal afferent nerves innervating mouse lungsJournal Of Physiology-London, 2008
- Automated electron microscope tomography using robust prediction of specimen movementsJournal of Structural Biology, 2005